Talphera, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Vincent J. Angotti, with a market cap of $40.7M.
Common questions about Talphera, Inc.
Talphera, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026.
Talphera, Inc. has approximately 15 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.